02.05.2014 • News • Mergers & Acquisitions (M&A) • AZ Electronic Materials • China Ministry of Commerce

Merck Receives Final Antitrust Clearance for AZ

Germany's Merck KGaA has received final clearance for the takeover of AZ Electronic Materials. This follows approval of the deal by China's Ministry of Commerce (MOFCOM).

Merck said the go-ahead from China means that the last antitrust hurdle has been taken. AZ shareholders now have until May 7 to tender their shares.

In December 2013, the Darmstadt-based chemicals and pharmaceuticals producer offered £1.6 billion in cash for the Luxembourg-based firm, which manufactures anti-reflective coatings used in hard disc drives, as well as specialty chemicals for the graphic arts sector and shrink coatings used in memory devices.

The offer was extended several times.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.